Eli Lilly hiked its revenue growth guidance by 7%, while Novo Nordisk was forced to slash its targets by ~12%. See why I'm still bullish on LLY stock.
Tired of slow, inconsistent image edits with ChatGPT or other AI tools (including Photoshop_? Discover how Flux Kontext ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback